Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Li Kang Biomedical Co., Ltd. (6242:TWSE), powered by AI.
Li Kang Biomedical Co., Ltd. is currently trading at $38.15. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Li Kang Biomedical Co., Ltd. on Alpha Lenz.
View Li Kang Biomedical Co., Ltd.'s valuation metrics on Alpha Lenz.
“Li Kang Biomedical Co., Ltd.'s ROE is 9.7%. Explore profitability and growth together.”
Ask for details →Li Kang Biomedical Co., Ltd. is a consumer-focused company specializing in the manufacture and sale of supplements, cosmeceuticals, and hygienic drink products. Originally established in 1982 and based in Tainan City, Taiwan, the company underwent a significant transition in 2014 when it shifted its business model from producing technology-related wiring and communication products to focusing on health and wellness sectors, particularly through its experience in Chinese herbal medicine. The company’s core operations integrate manufacturing with innovative channel strategies such as tourism factories, telemarketing, and partnerships with traditional Chinese medicine pharmacies. These specialized sales channels are designed to enhance brand reach and consumer accessibility, especially by leveraging the rising demand for hygienic drinks rooted in traditional medicinal materials. In addition to its product offerings, Li Kang Biomedical is involved in managing and consulting for tourism factory businesses, assisting conventional manufacturers in transitioning to service and tourism-oriented models. This multifaceted approach positions Li Kang Biomedical as a unique player bridging traditional wellness, modern retail, and experiential industry sectors within Taiwan’s consumer discretionary landscape.
“Li Kang Biomedical Co., Ltd.'s ROE is 9.7%. Explore profitability and growth together.”
Ask for details →Li Kang Biomedical Co., Ltd. (ticker: 6242) is a company listed on TWSE in the Consumer Cyclical sector (Travel Services). It has approximately 122 employees.
The current price is 38.15 with a P/E ratio of -x and P/B of -x.
ROE is 9.71% and operating margin is 16.68%. Annual revenue is $589M.